Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA.

Wang R, Braughton KR, Kretschmer D, Bach TH, Queck SY, Li M, Kennedy AD, Dorward DW, Klebanoff SJ, Peschel A, DeLeo FR, Otto M.

Nat Med. 2007 Dec;13(12):1510-4. Epub 2007 Nov 11.

PMID:
17994102
2.

Community-associated methicillin-resistant Staphylococcus aureus immune evasion and virulence.

Graves SF, Kobayashi SD, DeLeo FR.

J Mol Med (Berl). 2010 Feb;88(2):109-14. doi: 10.1007/s00109-009-0573-x. Epub 2010 Jan 5. Review.

3.

Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease?

Voyich JM, Otto M, Mathema B, Braughton KR, Whitney AR, Welty D, Long RD, Dorward DW, Gardner DJ, Lina G, Kreiswirth BN, DeLeo FR.

J Infect Dis. 2006 Dec 15;194(12):1761-70. Epub 2006 Nov 2.

4.

Hyperexpression of α-hemolysin explains enhanced virulence of sequence type 93 community-associated methicillin-resistant Staphylococcus aureus.

Chua KY, Monk IR, Lin YH, Seemann T, Tuck KL, Porter JL, Stepnell J, Coombs GW, Davies JK, Stinear TP, Howden BP.

BMC Microbiol. 2014 Feb 10;14:31. doi: 10.1186/1471-2180-14-31.

6.

Community-acquired methicillin-resistant Staphylococcus aureus infections.

Maltezou HC, Giamarellou H.

Int J Antimicrob Agents. 2006 Feb;27(2):87-96. Epub 2006 Jan 19. Review.

PMID:
16423509
8.

Community-associated methicillin-resistant Staphylococcus aureus skin infections: advances toward identifying the key virulence factors.

Nygaard TK, DeLeo FR, Voyich JM.

Curr Opin Infect Dis. 2008 Apr;21(2):147-52. doi: 10.1097/QCO.0b013e3282f64819. Review.

PMID:
18317037
9.

Secrets of a superbug.

Lowy FD.

Nat Med. 2007 Dec;13(12):1418-20. No abstract available.

PMID:
18064034
10.

Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin.

Boyle-Vavra S, Daum RS.

Lab Invest. 2007 Jan;87(1):3-9. Epub 2006 Dec 4. Review.

11.

Virulence gene expression in human community-acquired Staphylococcus aureus infection.

Loughman JA, Fritz SA, Storch GA, Hunstad DA.

J Infect Dis. 2009 Feb 1;199(3):294-301. doi: 10.1086/595982.

12.

Community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus virulence toward Caenorhabditis elegans compared.

Day SR, Moore CM, Kundzins JR, Sifri CD.

Virulence. 2012 Nov 15;3(7):576-82. doi: 10.4161/viru.22120. Epub 2012 Oct 17.

13.

The role of virulence determinants in community-associated MRSA pathogenesis.

Diep BA, Otto M.

Trends Microbiol. 2008 Aug;16(8):361-9. doi: 10.1016/j.tim.2008.05.002. Epub 2008 Jun 26. Review.

14.

Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China.

Wu D, Wang Q, Yang Y, Geng W, Wang Q, Yu S, Yao K, Yuan L, Shen X.

Diagn Microbiol Infect Dis. 2010 May;67(1):1-8. doi: 10.1016/j.diagmicrobio.2009.12.006. Epub 2010 Mar 12.

PMID:
20227225
15.

New patterns of methicillin-resistant Staphylococcus aureus (MRSA) clones, community-associated MRSA genotypes behave like healthcare-associated MRSA genotypes within hospitals, Argentina.

Egea AL, Gagetti P, Lamberghini R, Faccone D, Lucero C, Vindel A, Tosoroni D, Garnero A, Saka HA, Galas M; S. aureus Study Group-Argentina, Bocco JL, Corso A, Sola C.

Int J Med Microbiol. 2014 Nov;304(8):1086-99. doi: 10.1016/j.ijmm.2014.08.002. Epub 2014 Aug 12.

PMID:
25240872
16.

Community-acquired methicillin-resistant Staphylococcus aureus in Taiwan.

Chen CJ, Huang YC.

J Microbiol Immunol Infect. 2005 Dec;38(6):376-82. Review.

PMID:
16341337
17.

Community-acquired methicillin-resistant Staphylococcus aureus infections.

Palavecino E.

Clin Lab Med. 2004 Jun;24(2):403-18. Review.

PMID:
15177847
18.

Virulence genes and genotypic associations in nasal carriage, community-associated methicillin-susceptible and methicillin-resistant USA400 Staphylococcus aureus isolates.

Shukla SK, Karow ME, Brady JM, Stemper ME, Kislow J, Moore N, Wroblewski K, Chyou PH, Warshauer DM, Reed KD, Lynfield R, Schwan WR.

J Clin Microbiol. 2010 Oct;48(10):3582-92. doi: 10.1128/JCM.00657-10. Epub 2010 Jul 28.

19.

Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.

Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, Chen YC, Chang SC.

Clin Infect Dis. 2008 Mar 15;46(6):799-806. doi: 10.1086/527389.

20.

Comparison of community-acquired methicillin-resistant Staphylococcus aureus bacteremia to other staphylococcal species in a neonatal intensive care unit.

Kuint J, Barzilai A, Regev-Yochay G, Rubinstein E, Keller N, Maayan-Metzger A.

Eur J Pediatr. 2007 Apr;166(4):319-25. Epub 2006 Oct 19.

PMID:
17051356
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk